Coldstream Capital Management Inc Cognition Therapeutics Inc Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,243 shares of CGTX stock, worth $534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,243Holding current value
$534% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
13.5MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$2.58 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$948,3120.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$532,8410.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$261,6070.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$215,0000.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $9.77M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...